209401-69-4 Usage
Uses
Used in Pharmaceutical Industry:
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine is used as a potential candidate in drug discovery for its unique structure and properties that may contribute to the development of novel therapeutic agents.
Used in Material Development:
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine may be utilized in the development of new materials due to its heterocyclic nature and the possibility of its structural features influencing material properties.
Used as a Reagent in Chemical Reactions:
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine could serve as a reagent in various chemical processes, potentially due to its ability to participate in reactions that involve its nitrogen and oxygen atoms within the ring structure, thus facilitating new synthetic pathways or transformations.
Check Digit Verification of cas no
The CAS Registry Mumber 209401-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,4,0 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 209401-69:
(8*2)+(7*0)+(6*9)+(5*4)+(4*0)+(3*1)+(2*6)+(1*9)=114
114 % 10 = 4
So 209401-69-4 is a valid CAS Registry Number.
209401-69-4Relevant academic research and scientific papers
Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
-
, (2008/06/13)
PCT No. PCT/EP97/06781 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Dec. 4, 1997 PCT Pub. No. WO98/26779 PCT Pub. Date Jun. 25, 1998The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which a
Quinolonecarboxylic acids
-
, (2008/06/13)
The invention relates to novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid which are linked to a β-lactam antibiotic, to their salts, to processes for their preparation and to antibacterial agents containing these derivatives.
Enantiomerically pure 2-oxa-5,8-diazabicyclo[4.3.0]nonanes and process for their preparation
-
, (2008/06/13)
The invention relates to enantiomerically pure 2-oxa-5,8-diazabicyclo[4.3.0]nonanes and processes for their preparation. The starting, intermediate and end products are as follows: STR1
